文献速递癫痫

美国新发癫痫诊断与治疗之间差距的评估与影响

Assessment and effect of a gap between new-onset epilepsy diagnosis and treatment in the US.
PubMed 文献 · Neurology · 2019-04-10

基于Truven Health MarketScan等数据库的回顾性队列研究显示,新诊断癫痫患者中36.7%在诊断后3年内未接受抗癫痫药物治疗,验证队列为31.8%。未治疗与医疗事件、住院和急诊就诊风险增加相关。

要点

  • 约三分之一新诊断癫痫患者在诊断后3年内未启动抗癫痫药物治疗。
  • 未治疗者医疗事件调整IRR为1.2,住院为2.3,急诊就诊为2.8。
  • 诊断后延迟治疗可能增加可预防的医疗事件和资源利用。

核心结论

  • 新诊断癫痫患者中约三分之一在诊断后3年内仍未接受抗癫痫药物治疗,且未治疗与医疗事件及医疗资源利用增加相关。

研究设计与样本

  • 回顾性索赔数据库队列研究,使用Truven Health MarketScan数据库(商业及补充Medicare 2010-2015年,Medicaid 2010-2014年),主要研究纳入59,970人。
  • 验证研究使用PharMetrics Plus数据库链接LRx索赔数据库(2009-2014年),纳入30,890人。

主要发现

  • 主要研究中36.7%的新诊断癫痫患者在诊断后长达3年内未接受抗癫痫药物治疗。
  • 验证研究中31.8%的患者在诊断后长达3年内仍未治疗。
  • 未接受AED治疗者的调整发病率比(95%CI)为:医疗事件1.2(1.2-1.3),住院2.3(2.2-2.3),急诊就诊2.8(2.7-2.9)。

临床怎么用

  • 神经科医生应关注新诊断癫痫患者启动抗癫痫药物的及时性,识别并干预治疗延迟。
  • 对于未治疗患者,需评估延迟治疗对医疗事件及急诊就诊风险的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To estimate the treatment gap between a new epilepsy diagnosis and antiepileptic drug (AED) initiation in the United States. METHODS: Retrospective claims-based cohort study using Truven Health MarketScan databases (commercial and supplemental Medicare, calendar years 2010-2015; Medicaid, 2010-2014) and a validation study using PharMetrics Plus Database linked to LRx claims database (2009-2014). Persons met epilepsy diagnostic criteria, had an index date (first epilepsy diagnosis) with a preceding 2-year baseline (1 year for persons aged 1 to <2 years; none for persons <1 year), and continuous medical and pharmacy enrollment without epilepsy/seizure diagnosis or AED prescription during baseline. Outcomes included percentage of untreated persons (no AED prescription) up to 3 years' follow-up and comparative outcomes (incidence rate ratio: untreated persons/treated persons), including medical events and health care resource utilization. RESULTS: In the primary study, 59,970 persons met selection (or inclusion) criteria; 36.7% of persons with newly diagnosed epilepsy remained untreated up to 3 years after diagnosis. In the validation study (N = 30,890), 31.8% of persons remained untreated up to 3 years after diagnosis. Lack of AED treatment was associated with an adjusted incidence rate ratio (95% confidence interval) of 1.2 (1.2-1.3) for medical events, 2.3 (2.2-2.3) for hospitalizations, and 2.8 (2.7-2.9) for emergency department visits. CONCLUSIONS: One-third of newly diagnosed persons remain untreated up to 3 years after epilepsy diagnosis. The increased risk of medical events and health care utilization highlights the consequences of delayed treatment after epilepsy diagnosis, which might be preventable.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Kalilani L, Faught E, Kim H, et al. Assessment and effect of a gap between new-onset epilepsy diagnosis and treatment in the US. Neurology. 2019. PMID: 30971487. doi:10.1212/WNL.0000000000007448

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。